NTRA250117C75000
- 62.50
- 0.000.00%
Natera Newsroom
When Will Natera, Inc. (NASDAQ:NTRA) Breakeven?
Court Grants Natera's Request to Include Additional Patent in Its Lawsuit Against NeoGenomics
TD Cowen Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $195
Express News | Natera Inc : TD Cowen Raises Target Price to $195 From $175
Express News | Natera Inc : Guggenheim Raises Target Price to $170 From $165
Natera (NTRA) Receives a Buy From TD Cowen
Natera(NTRA.US) Officer Sells US$26.52 Million in Common Stock
$Natera(NTRA.US)$ Officer Rabinowitz Matthew sold 160K shares of common stock on Dec 13, 2024 at an average price of $165.7422 for a total value of $26.52 million.Source: Announcement What is
Natera Is Maintained at Overweight by JP Morgan
Natera Analyst Ratings
J.P. Morgan Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $200
Annual review | The top ten explosive stocks in the US stock market for 2024 have been released! Applovin emerges as the dark horse of the year in AI, MSTR astonishes the market with a fivefold increase for the year, and Tesla makes a comeback in the last
As of the market close on December 11, the S&P 500 Index has risen by 27% year-to-date, surpassing 6,000 points; the Nasdaq Composite Index has accumulated a rise of over 33%, reaching a milestone of 0.02 million points, exceeding market expectations.
Natera Announces Enrollment Of First Patients In SAGITTARIUS A Randomized Phase III Clinical Trial In Colon Cancer; ~700-900 Patients Expected To Be Enrolled Across More Than 20 Sites
Express News | Natera Inc - 700-900 Patients Expected to Be Enrolled in Trial
Express News | Natera Announces Enrollment of First Patients in Sagittarius: A Randomized, Phase III Clinical Trial in Colon Cancer
Natera Announces Enrollment of First Patients in SAGITTARIUS: a Randomized, Phase III Clinical Trial in Colon Cancer
Express News | Natera Inc : Leerink Partners Raises Target Price to $200 From $185
Natera and MyOme Announce Launch of IPRS for Breast Cancer Risk Assessment
Natera Aligns Executive Chairman's Pay With Performance
Natera(NTRA.US) Director Sells US$14.79 Million in Common Stock
$Natera(NTRA.US)$ Director BOTHA ROELOF sold 87,473 shares of common stock on Dec 2, 2024 at an average price of $169.1215 for a total value of $14.79 million.Source: Announcement What is statement
Natera Insider Sold Shares Worth $14,793,563, According to a Recent SEC Filing